Search
for
Sort by
Research 61–90 of 457
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- What is the Rationale for Androgen Therapy for Women?
- Emerging medication for the treatment of male hypogonadism
- Regulatory roles of androgens in cutaneous wound healing
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Increased Androgen Binding Capacity in Sebaceous Glands in Scalp of Male-pattern Baldness
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Changes of androgens levels in menopausal women
- Androgen receptors are only present in mesenchyme-derived dermal papilla cells of red deer (Cervus elaphus) neck follicles when raised androgens induce a mane in the breeding season
- Alterations in androgen conjugate levels in women and men with alopecia
- Weak correlations between serum and cerebrospinal fluid levels of estradiol, progesterone and testosterone in males
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Practical Geriatrics: Maintaining Sexual Health After Menopause
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- Saw palmetto (Serenoa repens) in androgenic alopecia An effective phytotherapy
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Testosterone: The Male Sex Hormone
- Benefits of Testosterone Replacement and Methods of Substitution
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Modelling androgen synthesis and action during human sexual differentiation
- Botanical Treatment for Polycystic Ovary Syndrome
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Impact of Hormones on Female Sexual Function and Dysfunction
- 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
- Clinical and Hormonal Evaluation of Androgen Excess
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Androgen insufficiency in women: diagnostic and therapeutic implications
- Ethosomes: An Exciting and Promising Alcoholic Carrier System for Treating Androgenic Alopecia